Biocept Competitors and Similar CompaniesClear all

Biocept's competitors and similar companies include Castle Biosciences.
Biocept
Biocept
Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
Castle Biosciences
Castle Biosciences
Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers.
Founding Date
Founding Date
1993
Founding Date
2008
Type
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
Friendswood, US HQ
Phoenix, US
Employees
Employees
878% decrease
Employees
61013% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
936.9 m

Financial

Revenue (est.)
Revenue (est.)
$25.9m (FY, 2022)
Revenue (est.)
$344.2m (FY, 2025)
Cost of goods
Cost of goods
$28.4m (FY, 2022)
Cost of goods
$71m (FY, 2025)
Gross profit
Gross profit
($2.5m) (FY, 2022)
Gross profit
$273.2m (FY, 2025)
Net income
Net income
($32.1m) (FY, 2022)
Net income
($24.2m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 15.9m
Total funding raised
$ 46.5m
For sources of this data, please see the company profile

View Company Profiles

Castle Biosciences
HQ
Friendswood, US
Employees
610↑ 13% increase

Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers.

View company